Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
NCT04853381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2022-05-18
Summary
Irritable Bowel Syndrome (IBS) is a disease associated with changes in bowel habits characterized by unexplained abdominal discomfort or pain. Common symptoms of the disease include gas, bloating, diarrhea, constipation, and common gastrointestinal problems associated with psychosocial problems. IBS makes it difficult for patients to attend school and work, reduce productivity, increase healthcare costs and negatively affect quality of life. Although IBS is not a life-threatening disease, it is a condition that must be tackled throughout life. The disease is clinically managed through dietary interventions and appropriate lifestyle changes, and pharmacological symptom-targeted or psychological treatments.
The aim of this study is to determine the effects of different dietary treatment methods on patients 'severity symptom score and quality of life, and the patients' compliance with different dietary treatments.
Conditions
- Irritable Bowel Syndrome
Interventions
- OTHER
-
dietary treatment (Traditional diet recommendations)
The aim of the study will be explained to the patients and the dietary treatment that will be recommended if they participate in the study will be told that they should be followed for 4 weeks. In addition, it will be notified that surveys will be conducted at the beginning and end of the 4-week period.
- OTHER
-
dietary treatment (low FODMAP)
The aim of the study will be explained to the patients and the dietary treatment that will be recommended if they participate in the study will be told that they should be followed for 4 weeks. In addition, it will be notified that surveys will be conducted at the beginning and end of the 4-week period.
- OTHER
-
dietary treatment (gluten free)
The aim of the study will be explained to the patients and the dietary treatment that will be recommended if they participate in the study will be told that they should be followed for 4 weeks. In addition, it will be notified that surveys will be conducted at the beginning and end of the 4-week period.
- OTHER
-
dietary treatment (low FODMAP+gluten free)
The aim of the study will be explained to the patients and the dietary treatment that will be recommended if they participate in the study will be told that they should be followed for 4 weeks. In addition, it will be notified that surveys will be conducted at the beginning and end of the 4-week period.
Sponsors & Collaborators
-
University of Gaziantep
lead OTHER
Principal Investigators
-
S.Mine YURTTAGUL · Hasan Kalyoncu University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-21
- Primary Completion
- 2021-12-22
- Completion
- 2022-01-12
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
(FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome
NCT07299305 ·Status: COMPLETED ·Phase: NA
-
Identification of IBS Metabotypes Based on Physiological Responses to Food
NCT03653689 ·Status: COMPLETED ·Phase: NA
-
Diet Reintroduction Study in Irritable Bowel Syndrome
NCT03052439 ·Status: COMPLETED ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Evaluating Diets for IBS
NCT05831306 ·Status: UNKNOWN ·Phase: NA
-
Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome
NCT02450370 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome
NCT04542018 ·Status: COMPLETED ·Phase: NA
-
The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS)
NCT01483287 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
NCT02980406 ·Status: COMPLETED ·Phase: NA
-
Dietary Treatment for IBS Within Primary Health Care
NCT05415488 ·Status: RECRUITING ·Phase: NA
-
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
NCT05985018 ·Status: COMPLETED ·Phase: NA
-
Identification of Gluten Sensitivity in Irritable Bowel Syndrome
NCT04017585 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT04373304 ·Status: UNKNOWN ·Phase: NA
-
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
NCT04072991 ·Status: COMPLETED ·Phase: NA
-
The Effect of AI-based Microbiome Diet on IBS-M Symptoms
NCT04768387 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Microbiota and Quality of Life for a Low FODMAPs and Standard Dietary in Irritable Bowel Syndrome Patients
NCT02902926 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS
NCT03306381 ·Status: COMPLETED ·Phase: NA
-
The Effects of FODMAPs in Patients With Irritable Bowel Syndrome
NCT05182593 ·Status: COMPLETED ·Phase: NA
-
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT03948854 ·Status: COMPLETED ·Phase: NA
-
Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention
NCT04193501 ·Status: UNKNOWN ·Phase: PHASE3
-
A Novel Probiotic Mixture in Adults With IBS
NCT06610149 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
Low FODMAP Diet on Nutritional Status, Disease Activity and Gut Microbiota in IBS and UC With Normal or Overweight BMI
NCT04143633 ·Status: UNKNOWN ·Phase: NA